Indian Expert Opinion on Cancer Care during COVID-19 Pandemic

Author:

Vaid Ashok K.1,Malhotra Hemant2,Thirumalairaj Raja3,Nair Reena4,Bapna Ajay5,Rajappa Senthil J.6,Somashekhar S. P.7,Goswami Chanchal8,Bajpai Jyoti9

Affiliation:

1. Department of Medical Oncology and Hematology, Medanta Cancer Institute, Medanta—The Medicity, Gurgaon, Haryana, India

2. Department of Medical Oncology, Sri Ram Cancer Center, Mahatma Gandhi University of Medical Sciences and Technology, Jaipur, Rajasthan, India

3. Department of Medical Oncology, Apollo Hospitals, Chennai, Tamil Nadu, India

4. Department of Clinical Hematology, Tata Medical Centre, Kolkata, West Bengal, India

5. Department of Medical Oncology, Bhagwan Mahaveer Cancer Hospital and Research Centre, Jaipur, Rajasthan, India

6. Department of Oncology, Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, Telangana, India

7. Department of Surgical Oncology, Manipal Comprehensive Cancer Center, Manipal Hospital, Bangalore, Karnataka, India

8. Oncology Services, Medica Institute of Breast Diseases, Medica Superspecialty Hospital, Kolkata, West Bengal, India

9. Department of Medical Oncology, Tata Memorial Hospital/Center, Mumbai, Maharashtra, India

Abstract

AbstractCoronavirus pandemic has increased human disease burden, as well as economic distress globally. Being in an immunocompromised state, patients with cancer comprise an important at-risk population for novel coronavirus disease 2019 (COVID-19) infection. It is necessary to modify individualized clinical management for every cancer patient in the context of the ongoing COVID-19 pandemic. Simultaneously, additional safety precautions for the cancer care providers are mandatory. This review will provide general recommendations in the Indian context optimizing the same.

Publisher

Georg Thieme Verlag KG

Subject

Cancer Research,Oncology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3